Responses
Immune cell therapies and immune cell engineering
Original research
Bispecific antibody-mediated redirection of NKG2D-CAR natural killer cells facilitates dual targeting and enhances antitumor activity
Compose a Response to This Article
Other responses
No responses have been published for this article.